Cell Line : MOR-CPR
Cellosaurus Index : CVCL_2620
Cellosaurus ID : MOR-CPR
CCLE Name
: MORCPR_LUNG
CTRP2 Name
: MORCPR
Cancer Type : lung
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| MOR-CPR | 16-beta-bromoandrosterone | CTRP2 | 0.0011 | 37.0000 |
|
| MOR-CPR | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | 968 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | AA-COCF3 | CTRP2 | 0.0081 | 270.0000 |
|
| MOR-CPR | ABT737 | CTRP2 | 0.0011 | 37.0000 |
|
| MOR-CPR | AC55649 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | AEW541 | CCLE | 0.0025 | 8.0000 |
|
| MOR-CPR | Afatinib | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | AGK-2 | CTRP2 | 0.0041 | 33.0000 |
|
| MOR-CPR | Alisertib | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MOR-CPR | AM-580 | CTRP2 | 0.0160 | 530.0000 |
|
| MOR-CPR | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | ASN 05257430 | CTRP2 | 0.0011 | 37.0000 |
|
| MOR-CPR | AT7867 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | austocystin D | CTRP2 | 0.0011 | 37.0000 |
|
| MOR-CPR | Axitinib | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | AZ-3146 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | azacitidine | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | AZD-7545 | CTRP2 | 0.0023 | 74.0000 |
|
| MOR-CPR | AZD4547 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | AZD6482 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | AZD7762 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | AZD8055 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | B02 | CTRP2 | 0.0041 | 130.0000 |
|
| MOR-CPR | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Bax channel blocker | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | BEC | CTRP2 | 0.0081 | 270.0000 |
|
| MOR-CPR | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Bexarotene | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BI-2536 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | BIBR-1532 | CTRP2 | 0.0081 | 270.0000 |
|
| MOR-CPR | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BIX-01294 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | blebbistatin | CTRP2 | 0.0041 | 130.0000 |
|
| MOR-CPR | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BMS-195614 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BMS-345541 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BMS-536924 | CTRP2 | 0.0011 | 37.0000 |
|
| MOR-CPR | BMS-754807 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | Bortezomib | CTRP2 | 0.0000 | 0.1300 |
|
| MOR-CPR | Bosutinib | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| MOR-CPR | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MOR-CPR | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | BRD-A94377914 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | BRD-K02251932 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K02492147 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K03536150 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K03911514 | CTRP2 | 0.0020 | 33.0000 |
|
| MOR-CPR | BRD-K04800985 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K09587429 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K13185470 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K13999467 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K16130065 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K16147474 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K20514654 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| MOR-CPR | BRD-K27188169 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K27188169:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MOR-CPR | BRD-K27224038 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K27986637 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K29086754 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K29313308 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K30019337 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K33199242 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K34099515 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K34222889 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K34485477 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | BRD-K35604418 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K37390332 | CTRP2 | 0.0010 | 17.0000 |
|
| MOR-CPR | BRD-K41334119 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K44224150 | CTRP2 | 0.0010 | 34.0000 |
|
| MOR-CPR | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K48334597 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K49290616 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K50799972 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K52037352 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K55116708 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K58730230 | CTRP2 | 0.0020 | 33.0000 |
|
| MOR-CPR | BRD-K61166597 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K71781559 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K71935468 | CTRP2 | 0.0025 | 83.0000 |
|
| MOR-CPR | BRD-K75293299 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K78574327 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K79669418 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K84807411 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K86535717 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K92856060 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | BRD-K96431673 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K96970199 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD-K99584050 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD1835 | CTRP2 | 0.0041 | 130.0000 |
|
| MOR-CPR | BRD4132 | CTRP2 | 0.0049 | 160.0000 |
|
| MOR-CPR | BRD4770 | CTRP2 | 0.0010 | 17.0000 |
|
| MOR-CPR | BRD55319 | CTRP2 | 0.0011 | 37.0000 |
|
| MOR-CPR | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | BRD6430 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | BRD8899 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | BRD8958 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | BRD9647 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | BRD9876 | CTRP2 | 0.0041 | 130.0000 |
|
| MOR-CPR | brefeldin A | CTRP2 | 0.0011 | 37.0000 |
|
| MOR-CPR | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Cabozantinib | CTRP2 | 0.0020 | 4.2000 |
|
| MOR-CPR | canertinib | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Carboplatin | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 47.0000 |
|
| MOR-CPR | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MOR-CPR | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | CAY10594 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | CD-1530 | CTRP2 | 0.0041 | 130.0000 |
|
| MOR-CPR | CD-437 | CTRP2 | 0.0011 | 18.0000 |
|
| MOR-CPR | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | cerulenin | CTRP2 | 0.0045 | 150.0000 |
|
| MOR-CPR | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | CHEMBL1222381 | CTRP2 | 0.0081 | 270.0000 |
|
| MOR-CPR | CHEMBL374350 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | CHIR-99021 | CTRP2 | 0.0024 | 80.0000 |
|
| MOR-CPR | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| MOR-CPR | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| MOR-CPR | CI-976 | CTRP2 | 0.0081 | 270.0000 |
|
| MOR-CPR | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | ciclosporin | CTRP2 | 0.0010 | 17.0000 |
|
| MOR-CPR | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | CIL41 | CTRP2 | 0.0049 | 160.0000 |
|
| MOR-CPR | CIL55 | CTRP2 | 0.0003 | 10.0000 |
|
| MOR-CPR | CIL55A | CTRP2 | 0.0024 | 80.0000 |
|
| MOR-CPR | CIL56 | CTRP2 | 0.0001 | 2.5000 |
|
| MOR-CPR | CIL70 | CTRP2 | 0.0012 | 40.0000 |
|
| MOR-CPR | cimetidine | CTRP2 | 0.0081 | 270.0000 |
|
| MOR-CPR | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Compound 1541A | CTRP2 | 0.0011 | 37.0000 |
|
| MOR-CPR | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Compound 23 citrate | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | Compound 7d-cis | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | Crizotinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| MOR-CPR | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MOR-CPR | cucurbitacin I | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| MOR-CPR | cyanoquinoline 11 | CTRP2 | 0.0041 | 130.0000 |
|
| MOR-CPR | Cyclophosphamide | CTRP2 | 0.0041 | 130.0000 |
|
| MOR-CPR | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | cytochalasin B | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | Dacarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Daporinad | CTRP2 | 0.0000 | 0.2600 |
|
| MOR-CPR | darinaparsin | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | Dasatinib | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MOR-CPR | dexamethasone | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MOR-CPR | Doramapimod | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Doxorubicin | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MOR-CPR | ELCPK | CTRP2 | 0.0000 | 0.4000 |
|
| MOR-CPR | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Entinostat | CTRP2 | 0.0160 | 66.0000 |
|
| MOR-CPR | epigallocatechin-3-monogallate | CTRP2 | 0.0090 | 300.0000 |
|
| MOR-CPR | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Erlotinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| MOR-CPR | erlotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MOR-CPR | etomoxir | CTRP2 | 0.0090 | 300.0000 |
|
| MOR-CPR | Etoposide | CTRP2 | 0.0009 | 28.0000 |
|
| MOR-CPR | Fedratinib | CTRP2 | 0.0011 | 37.0000 |
|
| MOR-CPR | FGIN-1-27 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| MOR-CPR | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Foretinib | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | FQI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | FQI-2 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | FSC231 | CTRP2 | 0.0081 | 270.0000 |
|
| MOR-CPR | Fulvestrant | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| MOR-CPR | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | GDC-0879 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Gefitinib | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Gemcitabine | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | GMX-1778 | CTRP2 | 0.0000 | 0.2900 |
|
| MOR-CPR | gossypol | CTRP2 | 0.0011 | 37.0000 |
|
| MOR-CPR | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | GW-405833 | CTRP2 | 0.0041 | 130.0000 |
|
| MOR-CPR | HC-067047 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | hyperforin | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | I-BET-762 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | I-BET151 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | IC-87114 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Idelalisib | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | ifosfamide | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Imatinib | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | importazole | CTRP2 | 0.0061 | 200.0000 |
|
| MOR-CPR | indisulam | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | isoevodiamine | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | isoliquiritigenin | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| MOR-CPR | itraconazole | CTRP2 | 0.0005 | 17.0000 |
|
| MOR-CPR | IU1 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0081 | 66.0000 |
|
| MOR-CPR | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MOR-CPR | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MOR-CPR | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MOR-CPR | JQ1 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Ki8751 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Ko-143 | CTRP2 | 0.0041 | 130.0000 |
|
| MOR-CPR | KU 0060648 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | KU-55933 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | KU-60019 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | L-685458 | CTRP2,CCLE | 0.0011 | 37.0000 |
|
| MOR-CPR | Lapatinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| MOR-CPR | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | LBW242 | CCLE | 0.0025 | 8.0000 |
|
| MOR-CPR | LE-135 | CTRP2 | 0.0020 | 17.0000 |
|
| MOR-CPR | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Linifanib | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Linsitinib | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | lovastatin acid | CTRP2 | 0.0041 | 130.0000 |
|
| MOR-CPR | LY-2157299 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | LY-2183240 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | manumycin A | CTRP2 | 0.0009 | 30.0000 |
|
| MOR-CPR | Masitinib | CTRP2 | 0.0020 | 33.0000 |
|
| MOR-CPR | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Merck60 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | Methotrexate | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | MI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| MOR-CPR | MK-0752 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | MK-2206 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | ML006 | CTRP2 | 0.0160 | 530.0000 |
|
| MOR-CPR | ML030 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | ML050 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | ML203 | CTRP2 | 0.0011 | 37.0000 |
|
| MOR-CPR | ML210 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | ML258 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| MOR-CPR | ML312 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | ML320 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | myricetin | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | myriocin | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | N9-isopropylolomoucine | CTRP2 | 0.0120 | 400.0000 |
|
| MOR-CPR | nakiterpiosin | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | Navitoclax | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| MOR-CPR | necrostatin-1 | CTRP2 | 0.0160 | 530.0000 |
|
| MOR-CPR | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Nelarabine | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | neratinib | CTRP2 | 0.0010 | 17.0000 |
|
| MOR-CPR | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | Nilotinib | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | NPC-26 | CTRP2 | 0.0012 | 40.0000 |
|
| MOR-CPR | NSC 74859 | CTRP2 | 0.0160 | 530.0000 |
|
| MOR-CPR | NSC23766 | CTRP2 | 0.0160 | 530.0000 |
|
| MOR-CPR | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | NSC632839 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | NSC95397 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | Nutlin-3a | CTRP2,CCLE | 0.0025 | 150.0000 |
|
| MOR-CPR | NVP-ADW742 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | NVP-TAE684 | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| MOR-CPR | Obatoclax Mesylate | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Olaparib | CTRP2 | 0.0045 | 150.0000 |
|
| MOR-CPR | oligomycin A | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | OSI-027 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | OSI-930 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| MOR-CPR | Oxaliplatin | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | PAC-1 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | Paclitaxel | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| MOR-CPR | pandacostat | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | Panobinostat | CCLE | 0.0025 | 8.0000 |
|
| MOR-CPR | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Parthenolide | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Pazopanib | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | PD0325901 | CCLE | 0.0025 | 8.0000 |
|
| MOR-CPR | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Pevonedistat | CTRP2 | 0.0011 | 37.0000 |
|
| MOR-CPR | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | PF-750 | CTRP2 | 0.0081 | 270.0000 |
|
| MOR-CPR | PHA-665752 | CCLE | 0.0025 | 8.0000 |
|
| MOR-CPR | PHA-793887 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | phloretin | CTRP2 | 0.0180 | 590.0000 |
|
| MOR-CPR | PI-103 | CTRP2 | 0.0011 | 37.0000 |
|
| MOR-CPR | Pictilisib | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | pifithrin-alpha | CTRP2 | 0.0071 | 230.0000 |
|
| MOR-CPR | pifithrin-mu | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | PIK-93 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Piperlongumine | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | piperlongumine:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 4.2000 |
|
| MOR-CPR | PL-DI | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | pluripotin | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | PLX-4032 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | PLX-4720 | CTRP2,CCLE | 0.0010 | 33.0000 |
|
| MOR-CPR | PRIMA-1 | CTRP2 | 0.0051 | 170.0000 |
|
| MOR-CPR | PRIMA-1MET | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | PRL-3 Inhibitor I | CTRP2 | 0.0041 | 130.0000 |
|
| MOR-CPR | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | prochlorperazine | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | purmorphamine | CTRP2 | 0.0046 | 150.0000 |
|
| MOR-CPR | PX-12 | CTRP2 | 0.0030 | 100.0000 |
|
| MOR-CPR | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | QS11 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | Quizartinib | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | RAF265 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Rapamycin | CTRP2 | 0.0010 | 8.3000 |
|
| MOR-CPR | Regorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | RG-108 | CTRP2 | 0.0081 | 270.0000 |
|
| MOR-CPR | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | RITA | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | Ruxolitinib | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0066 | 220.0000 |
|
| MOR-CPR | Saracatinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| MOR-CPR | SB-225002 | CTRP2 | 0.0011 | 37.0000 |
|
| MOR-CPR | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | SCH-529074 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | SCH-79797 | CTRP2 | 0.0011 | 37.0000 |
|
| MOR-CPR | Selisistat | CTRP2 | 0.0024 | 80.0000 |
|
| MOR-CPR | Selumetinib | CTRP2,CCLE | 0.0025 | 270.0000 |
|
| MOR-CPR | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| MOR-CPR | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| MOR-CPR | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| MOR-CPR | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| MOR-CPR | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| MOR-CPR | selumetinib:piperlongumine (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| MOR-CPR | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| MOR-CPR | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 |
|
| MOR-CPR | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| MOR-CPR | selumetinib:vorinostat (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| MOR-CPR | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Sepantronium bromide | CTRP2 | 0.0000 | 1.0000 |
|
| MOR-CPR | Serdemetan | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | SID 26681509 | CTRP2 | 0.0090 | 300.0000 |
|
| MOR-CPR | sildenafil | CTRP2 | 0.0160 | 530.0000 |
|
| MOR-CPR | silmitasertib | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | simvastatin | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| MOR-CPR | sitagliptin | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | SJ-172550 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | SKI-II | CTRP2 | 0.0041 | 130.0000 |
|
| MOR-CPR | SMER-3 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | SN-38 | CTRP2 | 0.0000 | 1.3000 |
|
| MOR-CPR | SNS-032 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | SNX-2112 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| MOR-CPR | Sorafenib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| MOR-CPR | spautin-1 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Sphingosine Kinase 1 Inhibitor II | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | SR-II-138A | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Staurosporine | CTRP2 | 0.0001 | 3.3000 |
|
| MOR-CPR | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | SU11274 | CTRP2 | 0.0020 | 33.0000 |
|
| MOR-CPR | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | T-5345967 | CTRP2 | 0.0160 | 530.0000 |
|
| MOR-CPR | tacrolimus | CTRP2 | 0.0023 | 74.0000 |
|
| MOR-CPR | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | Tamoxifen | CTRP2 | 0.0030 | 100.0000 |
|
| MOR-CPR | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Tanespimycin | CTRP2,CCLE | 0.0010 | 33.0000 |
|
| MOR-CPR | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| MOR-CPR | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | Telomerase Inhibitor IX | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | Temozolomide | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Temsirolimus | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Teniposide | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | TGX221 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | tigecycline | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | tipifarnib-P1 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | tipifarnib-P2 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | Tivozanib | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | TKI258 | CCLE | 0.0025 | 8.0000 |
|
| MOR-CPR | Topotecan | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| MOR-CPR | tosedostat | CTRP2 | 0.0081 | 270.0000 |
|
| MOR-CPR | TPCA-1 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Tretinoin | CTRP2 | 0.0041 | 130.0000 |
|
| MOR-CPR | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| MOR-CPR | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| MOR-CPR | trifluoperazine | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | triptolide | CTRP2 | 0.0000 | 0.2900 |
|
| MOR-CPR | Tubastatin A | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | TW 37 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | UNC0321 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | UNC0638 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | valdecoxib | CTRP2 | 0.0180 | 600.0000 |
|
| MOR-CPR | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Veliparib | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | VER-155008 | CTRP2 | 0.0011 | 37.0000 |
|
| MOR-CPR | Vincristine | CTRP2 | 0.0041 | 130.0000 |
|
| MOR-CPR | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | Vorinostat | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | WZ8040 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | YK-4-279 | CTRP2 | 0.0010 | 33.0000 |
|
| MOR-CPR | YL54 | CTRP2 | 0.0020 | 66.0000 |
|
| MOR-CPR | ZD-6474 | CCLE | 0.0025 | 8.0000 |
|
| MOR-CPR | zebularine | CTRP2 | 0.0180 | 590.0000 |
|
| MOR-CPR | ZSTK474 | CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC